4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-N-methylpyridine-2-carboxamide | 1440964-75-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 4-[3-[difluoro-(6-fluoro-2-methylindazol-5-yl)methyl]-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-N-methylpyridine-2-carboxamide
• CAS: 1440964-75-9
• 化学式: C₂₁H₁₅F₃N₈O
• 分子量: 452.398
• InChiKey: LJFDNPYYPWYXOO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  33
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  103
• 氢给体数：
  1
• 氢受体数：
  9

文献信息

• HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS
  申请人：CROWN BIOSCIENCE INC. (TAIWAN)

  公开号：US20150218171A1

  公开（公告）日：2015-08-06

  Disclosed are novel nitrogen-containing, heterocyclic, c-Met inhibitor compounds, processes for their preparation and formulations thereof. The compounds are useful as therapeutical agents for the inhibition, regulation, and control of c-Met kinase signal pathway, and useful for treating in a subject a cell proliferative disorder or disorders mediated by c-Met.

  本发明涉及一种新颖的含氮、杂环、c-Met抑制剂化合物，其制备方法及其制剂。该化合物可用作治疗剂，用于抑制、调节和控制c-Met激酶信号通路，并用于治疗由c-Met介导的主体的细胞增殖性疾病或疾病。
• CANCER TREATMENT USING COMBINATION OF NEUTROPHIL MODULATOR WITH MODULATOR OF IMMUNE CHECKPOINT
  申请人：APOLLOMICS INC.

  公开号：US20200405719A1

  公开（公告）日：2020-12-31

  The present disclosure provides methods of treating a cancer in a subject. The method includes a step of measuring a base level of a biomarker selected from a group consisting of hepatocyte growth factor, absolute neutrophil count, c-Met+ neutrophils and neutrophil to lymphocyte ratio (NLR) in the subject. The method also includes the steps of determining that the base level of said biomarker is equal or more than a threshold value or determining the change in the said biomarker upon administration of an immune checkpoint modulator is equal or more than a threshold value; and administering to the subject a combination of c-Met inhibitor and a modulator of an immune checkpoint.
• US9695175B2
  申请人：——

  公开号：US9695175B2

  公开（公告）日：2017-07-04